Sanofi Expects To File BLA For Quadrivalent Flu Vaccine Within A Year
This article was originally published in The Pink Sheet Daily
Executive Summary
Initial clinical study found efficacy and safety comparable for quadrivalent and trivalent vaccines; second pivotal trial to be conducted in the fall.